Novo-Nordisk A/S (NVO) is a publicly traded Healthcare sector company. As of October 1, 2026, NVO trades at $37.93 with a market cap of $169.16B and a P/E ratio of 0.00. NVO moved -1.00% today. Year to date, NVO is -27.64%; over the trailing twelve months it is -31.68%. Its 52-week range spans $35.12 to $93.80. Analyst consensus is neutral with an average price target of $43.70. Rallies surfaces NVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Novo-Nordisk A/S (NVO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NVO moved -1.00% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $37.93 |
| Market Cap | $169.16B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.58% |
| 52-Week High | $93.80 |
| 52-Week Low | $35.12 |
| Volume | 19.03M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
7 analysts cover NVO: 0 strong buy, 0 buy, 6 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $43.70.